Edward Cox

Senior Vice President, Regulatory Affairs · Regeneron Pharmaceuticals

Biopharmaceuticals

Edward Cox is senior vice president of regulatory affairs at Regeneron Pharmaceuticals. He joined in 2019 after more than two decades at the U.S. Food and Drug Administration, including thirteen years directing the Office of Antimicrobial Products.

Last reviewed: Oct 21, 2026

Edward Cox

Senior Vice President, Regulatory Affairs Regeneron Pharmaceuticals

Last Reviewed: October 21, 2026

Executive Summary

Edward Cox is senior vice president of regulatory affairs at Regeneron Pharmaceuticals. He joined in 2019 after more than two decades at the U.S. Food and Drug Administration, including thirteen years directing the Office of Antimicrobial Products.

Career Highlights

  • Joined Regeneron in 2019.
  • Spent thirteen years as director of the FDA’s Office of Antimicrobial Products.
  • Now oversees regulatory strategy and operations across the product lifecycle.

Professional Journey

Cox trained in internal medicine at the Hospital of the University of Pennsylvania and completed an infectious disease fellowship at the National Institutes of Health. He subsequently spent more than twenty years at the FDA.

For thirteen years, he directed the Office of Antimicrobial Products, leading review, approval and safety oversight of antimicrobial and immunosuppressive medicines. His work included clinical trial design, responses to H1N1 and Ebola, and efforts addressing antimicrobial resistance and emerging infections.

He joined Regeneron in 2019. His current responsibilities include strategic regulatory guidance across the product lifecycle, regulatory operations, medical writing, in vitro diagnostics, labeling and advertising and promotion.

Education

Cox earned his medical degree from the University of North Carolina School of Medicine, an MPH from Johns Hopkins University and a BS in chemistry from the University of North Carolina at Chapel Hill, where he was a Morehead Scholar.